menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Assessing the Effectiveness of Intravenous Ertapenem in HS Patients

ReachMD Healthcare Image
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Comments
  • Overview

    Recalcitrant hidradenitis suppurativa (HS) is a severe and progressive form of HS that is resistant to conventional therapies. So a recent study aimed to look at the effectiveness of intravenous ertapenem to potentially improve clinical outcomes, inflammatory markers, and patient satisfaction in those who have this chronic skin condition. Learn more about this study and what it means for patients with recalcitrant HS.

Facebook Comments

Recommended
Details
Comments
  • Overview

    Recalcitrant hidradenitis suppurativa (HS) is a severe and progressive form of HS that is resistant to conventional therapies. So a recent study aimed to look at the effectiveness of intravenous ertapenem to potentially improve clinical outcomes, inflammatory markers, and patient satisfaction in those who have this chronic skin condition. Learn more about this study and what it means for patients with recalcitrant HS.

Facebook Comments

Schedule24 May 2024